-
Views
-
Cite
Cite
Oded Friedman, Alexander G. Logan, The Price of Obstructive Sleep Apnea–Hypopnea: Hypertension and Other Ill Effects, American Journal of Hypertension, Volume 22, Issue 5, May 2009, Pages 474–483, https://doi.org/10.1038/ajh.2009.43
- Share Icon Share
Abstract
This review addresses the cardiovascular, cerebrovascular, and metabolic consequences that accompany obstructive sleep apnea–hypopnea (OSAH) in conjunction with the mechanistic pathways implicated in mediating these effects. Particular emphasis is placed on the association with hypertension (HTN). Varying levels of evidence support a role of OSAH in perpetuating sustained HTN, nocturnal HTN, and difficult to control HTN as well as in contributing to the occurrences of nondipping of blood pressure (BP) and increased BP variability. In this context, the emergence of matched designs, adjusted analyses, meta-analyses as well as longitudinal and interventional studies strengthens causal inferences drawn from older observational studies, which suffered from such limitations as confounding.